Seek Labs Presents at the Animal Health, Nutrition & Technology Innovation Asia Summit in Tokyo, Japan
October 19, 2023
SALT LAKE CITY, UT, October, 18, 2023 – Seek Labs, a healthcare innovations company doing research in infectious disease diagnostic systems and pharmaceuticals, is pleased to announce its participation at the Animal Health, Nutrition & Technology Innovation Asia Summit in Tokyo, Japan. Craig Mosman, Chief Business Development Officer, was invited to speak on behalf of Seek Labs–one of only five companies invited to present–as part of the conference’s scheduled programming.
The Animal Health, Nutrition & Technology Innovation Asia Summit engages key stakeholders to address how animal health impacts pet owners, veterinarians, and farmers worldwide.
Mosman presented on Seek Labs’s pharmaceutical technology, which utilizes novel genetically engineered constructs (GECs) to target the cellular replication of diseases. The presentation specifically focused on how Seek’s novel GECs have applications in animal diseases, including African Swine Fever Virus (ASFV) and White Spot Syndrome Virus (WSSV).
About Seek Labs
Seek Labs is a company united by a vision to advance scientific discovery and universal solutions. Seek Labs strives to innovate healthcare solutions that bridge gaps between patients, providers, and remedies. Seek Labs is united by the passion of our founders and their shared beliefs that healthcare solutions should empower individuals and serve their specific needs. Today—after years of experimentation, failure, and breakthrough—Seek Labs is pursuing impactful diagnostic and pharmaceutical technologies that revolutionize point of care.
Seek Labs is headquartered in Salt Lake City, Utah. Seek Labs is a member of the BioHive, the Utah life sciences industry collective.
CONTACT
Bridget Baldwin
Director of Communications
bridget@seeklabs.com
Recent News
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
- Sera Prognostics Appoints Scott Gleason CFO
- Merit Medical Announces Global Operations Leadership Transition
- Utah Life Sciences Innovation Caucus Breakfast
- Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
